MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will present at the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, providing investors with an update as the medical technology company continues to commercialize products for soft-tissue reconstruction.
The company announced that management is scheduled to present at 8:30 a.m. ET during the conference. A live webcast and archived replay will be available through TELA Bio’s investor relations website at https://ir.telabio.com.
The Canaccord Genuity Annual Growth Conference is a widely followed event that brings together public companies and institutional investors across multiple sectors.
TELA Bio develops soft-tissue reconstruction technologies designed to preserve and restore patients’ natural anatomy. The company’s products are intended to support the body’s healing response while reducing long-term exposure to permanent synthetic materials used in surgical reconstruction.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.